Oppenheimer & Co Inc’s Abbvie Inc Position
Does Oppenheimer & Co Inc own Abbvie Inc (ABBV)? Yes — 156.1K shares worth $34M (+0.41% of its 13F portfolio) as of Q1 2026, down from 159.4K shares the prior filed quarter.
Position Value
$34M
Q1 2026
Shares
156.1K
% of Portfolio
+0.41%
Quarters Held
30
currently held
Position History ABBV
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 156.1K | $34M | +0.41% |
| Q4 2025 | 159.4K | $36M | +0.52% |
| Q3 2025 | 167.5K | $39M | +0.47% |
| Q2 2025 | 161.9K | $30M | +0.40% |
| Q1 2025 | 152.6K | $32M | +0.48% |
| Q4 2024 | 149.9K | $27M | +0.40% |
| Q3 2024 | 148.8K | $29M | +0.45% |
| Q2 2024 | 153.6K | $26M | +0.42% |
| Q1 2024 | 150.4K | $27M | +0.45% |
| Q4 2023 | 155.3K | $24M | +0.44% |
| Q3 2023 | 152.5K | $23M | +0.47% |
| Q2 2023 | 155.0K | $21M | +0.42% |
| Q1 2023 | 169.2K | $27M | +0.57% |
| Q4 2022 | 159.4K | $26M | +0.59% |
| Q3 2022 | 161.1K | $22M | +0.51% |
| Q2 2022 | 166.9K | $26M | +0.55% |
| Q1 2022 | 175.8K | $28M | +0.51% |
| Q4 2021 | 186.0K | $25M | +0.44% |
| Q3 2021 | 190.2K | $21M | +0.38% |
| Q2 2021 | 183.2K | $21M | +0.37% |
| Q1 2021 | 183.1K | $20M | +0.40% |
| Q4 2020 | 175.5K | $19M | +0.40% |
| Q3 2020 | 178.9K | $16M | +0.39% |
| Q2 2020 | 269.0K | $26M | +0.68% |
| Q1 2020 | 213.7K | $16M | +0.49% |
| Q4 2019 | 194.4K | $17M | +0.43% |
| Q3 2019 | 166.5K | $13M | +0.34% |
| Q2 2019 | 160.2K | $12M | +0.32% |
| Q1 2019 | 128.1K | $10M | +0.28% |
| Q4 2018 | 190.1K | $18M | +0.55% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Oppenheimer & Co Inc’s full portfolio or all institutional holders of ABBV.